Nanoscope Therapeutics Inc.
PrivateLast Round
Grant
Sep 14, 2021
Total Funding Raised
$14.83M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nanoscope Therapeutics Inc. is a biotechnology company developing gene-agnostic, vision-restoring optogenetic therapies for patients blinded by retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanoscope Therapeutics Inc. Comparables
Compare Nanoscope Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 86% | |
| SparingVision | 85% | |
| Gensight Biologics | 84% |
Nanoscope Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 14, 2021 | ||||
| Series A | Jul 21, 2020 | ||||
| Grant | Jun 22, 2020 |
Nanoscope Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| AG Collective Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 32% MoM.
- Jul 25, 2026
Monthly visitors increased 62% MoM, reaching 7.5K.
Recent news
Latest coverage and updates
- hiresOct 14, 2026
Nanoscope Therapeutics, Inc. appoints Troy Short as Senior Vice President, Manufacturing and Supply Chain in Texas on Oct 14th '26'; he leads GMP manufacturing, commercial supply, and global distribution strategy as the company advances MOGENRY toward potential approval and launch.
- attends_eventSep 23, 2026
Nanoscope Therapeutics, Inc. is scheduled to present data from its geographic atrophy and retinitis pigmentosa programs at the 26th Euretina Congress in Austria on Oct 1st-4th '26.
- attends_eventSep 23, 2026
Nanoscope Therapeutics, Inc. presents Macular Degeneration and Retinitis Pigmentosa data at the Ophthalmology Futures Forums Retina Forum on Sep 30th '26 and at the 26th Euretina Congress on Oct 1st–4th '26, both in Austria.
- attends_eventSep 15, 2026
Nanoscope Therapeutics, Inc. announces that Dr. Christine Kay presents four-year MCO-010 retinitis pigmentosa data at the 59th Annual Scientific Meeting of the Retina Society in California from Sep 23rd–26th '26.
Nanoscope Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanoscope Therapeutics Inc.'s valuation, stock price, and market status.
Is Nanoscope Therapeutics Inc. a public or private company?
Nanoscope Therapeutics Inc. is a private company.
What is the current stock price of Nanoscope Therapeutics Inc.?
Nanoscope Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Nanoscope Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanoscope Therapeutics Inc. worth (valuation)?
Valuation information for Nanoscope Therapeutics Inc. is not publicly available.
Can I buy Nanoscope Therapeutics Inc. stock?
Nanoscope Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanoscope Therapeutics Inc.'s last funding round?
Nanoscope Therapeutics Inc.'s most recent funding round was Grant on September 14, 2021.
Who are the main investors in Nanoscope Therapeutics Inc.?
Key investors in Nanoscope Therapeutics Inc. include NIH RADx, AG Collective Capital.
Will Nanoscope Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Nanoscope Therapeutics Inc..
How can I track Nanoscope Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nanoscope Therapeutics Inc.'s shares on secondary markets.